Metagenomi Therapeutics, Inc. (MGX) Revenue 2023–2025
Metagenomi Therapeutics, Inc. (MGX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$25.2MFY2025 · since FY2023: $44.8M → $25.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $25.2M | -51.8% |
| FY2024 | $52.3M | +16.8% |
| FY2023 | $44.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice